Insider · CIK 0002082083
Cory Randall Ellspermann
Files at INMB (Inmune Bio, Inc.). First filing -, latest -.
In brief
Cory Randall Ellspermann files SEC Form 4 as CFO at INMB (Inmune Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cory Randall Ellspermann has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | INMB Inmune Bio, Inc. | AGrant or award Option (right to buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Dec 2, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -75,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +75,000 | - | - | 75,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -40,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | - | - | 40,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | - | - | 30,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -70,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +70,000 | - | - | 70,000 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Nov 18, 2025 |
| Nov 18, 2025 | INMB Inmune Bio, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | - | - | 30,000 | Nov 18, 2025 |
Questions about Cory Randall Ellspermann
Answered from the filings on this page, as of the latest one.
Is Cory Randall Ellspermann buying or selling?
Cory Randall Ellspermann has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cory Randall Ellspermann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cory Randall Ellspermann has 0.
Where does Cory Randall Ellspermann file Form 4?
Cory Randall Ellspermann has filed Form 4 at INMB (Inmune Bio, Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.